About Synergia Life Sciences
Synergia Life Sciences is a company based in Iselin (United States) founded in 2004 was acquired by Novozymes in November 2021. Synergia Life Sciences has raised $5.96 million across 1 funding round from investors including Novozymes and InvAscent. The company has 119 employees as of April 05, 2024.
- Headquarter Iselin, United States
- Employees 119 as on 05 Apr, 2024
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synergia Life Sciences Private Limited
- Date of Incorporation 29 Mar, 2004
- Jurisdiction Wada, Maharashtra, India
-
Annual Revenue
$31.12 M (USD)16.29as on Mar 31, 2023
-
Net Profit
$12.22 M (USD)57.86as on Mar 31, 2023
-
EBITDA
$16.76 M (USD)53.88as on Mar 31, 2023
-
Total Equity Funding
$5.96 M (USD)
in 1 rounds
-
Latest Funding Round
$5.96 M (USD), Series A
Dec 15, 2015
-
Investors
Novozymes
& 1 more
-
Employee Count
119
as on Apr 05, 2024
-
Acquired by
Novozymes
(Nov 30, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Synergia Life Sciences
Synergia Life Sciences has successfully raised a total of $5.96M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.96 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Synergia Life Sciences
Synergia Life Sciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Novozymes and InvAscent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life sciences investments in India.
|
Locked | Locked | Locked | |
|
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
Locked | Locked | Locked |
Investor details for Synergia Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synergia Life Sciences
Investment portfolio details for Synergia Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synergia Life Sciences
Detailed financials for Synergia Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synergia Life Sciences Comparisons
Peer comparison for Synergia Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synergia Life Sciences
Detailed competitors of Synergia Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synergia Life Sciences
Complete news archive for Synergia Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synergia Life Sciences
Synergia Life Sciences was founded in 2004 and raised its 1st funding round 11 years after it was founded.
Synergia Life Sciences is headquartered in Iselin, United States. It is registered at Iselin, New Jersey, United States.
Dilip Mehta is the current CEO of Synergia Life Sciences.
Synergia Life Sciences is a funded company, having raised a total of $5.96M across 1 funding round to date.
As of Apr 05, 2024, the latest employee count at Synergia Life Sciences is 119.
Annual revenue of Synergia Life Sciences is $31.12M as on Mar 31, 2023.
Synergia Life Sciences was established in 2004 in Iselin, United States, as a manufacturer within the life sciences sector. Nutritional supplements are produced and distributed by the company, with operations centered on product formulation and quality control. Leadership is provided by CEO Dilip Mehta. The domain synergialifesciences.com is utilized for online presence, supporting activities in the health and wellness industry across the United States.